Avsnitt
-
On this episode of This Week in Pharmacy, we bring together three powerful voices shaping the future of pharmacy, independent practice, functional medicine, and healthcare transformation.
First, we welcome Kris Rhea, MBA, Contributing Editor with Dispense Times, a digital publication dedicated to supporting independent community pharmacy owners across the United States. Kris brings a business-focused perspective on pharmacy operations, growth strategy, workflow efficiency, data-driven decision-making, and market positioning. His work with Dispense Times helps independent pharmacists navigate today’s rapidly changing healthcare landscape, including PBM pressures, evolving patient expectations, regulatory challenges, and the need for sustainable business models that keep local pharmacies strong.
We also speak with James Maskell, founder of Evolution of Medicine, an organization built to inspire, equip, and unite functional and integrative medicine practitioners. Evolution of Medicine provides education, practice-building resources, and community for clinicians who are working to build thriving practices rooted in whole-person care. James brings a national perspective on the movement toward functional medicine, community-based care, prevention, and new models that empower practitioners to better serve patients beyond the limitations of conventional healthcare.
Our third guest is Marina Buksov, PharmD, a pharmacist, herbalist, educator, podcast host, and holistic health consultant. After earning her PharmD from St. John’s University and graduating Summa Cum Laude in 2013, Marina entered pharmacy eager to serve patients, but quickly recognized that traditional allopathic pharmacy did not fully align with her deeper calling to help people thrive through prevention, root-cause care, plant medicine, and sustainable wellness strategies. Her experience behind the pharmacy counter and as a patient herself inspired her to pursue health coaching, nutrition, functional medicine, and clinical herbalism. Today, Marina helps pharmacists and healthcare professionals explore natural-minded career paths and build meaningful work that bridges pharmacology, herbal therapeutics, and holistic care.
Together, this episode explores where pharmacy is headed: independent pharmacy survival, business model innovation, functional medicine, patient-centered care, pharmacist reinvention, and the growing demand for healthcare professionals who can connect science, prevention, and real-world practice.
Listen to This Week in Pharmacy on the Pharmacy Podcast Network.Pharmacy’s future is being built by those willing to challenge the current model, support independent practice, and expand the role of pharmacists as trusted healthcare providers.
-
In this episode, Sheila Arquette, President & CEO of NASP, speaks with Jonathan L. Swichar, Duane Morris Pharmacy Litigation Group Chair, and Bradley A. Wasser, Duane Morris Pharmacy Litigation Group Partner. They discuss the 2026 Consolidated Appropriations Act and its landmark PBM reform provisions that impact pharmacy network access and transparency. These expert litigators go into detail about what specialty pharmacies should expect as federal agencies enforce the new law and what opportunities and challenges lie ahead for specialty pharmacies.
-
Saknas det avsnitt?
-
In this episode of The Executive Dose Podcast, host Stephen Beckman leads a timely discussion on how pharmaceutical manufacturers approach portfolio ideation, portfolio development, and strategic growth in today’s increasingly complex healthcare environment.
Stephen is joined by Joe Hendrickson, Head of Strategy and Corporate Development for Serovia, for a conversation focused on how manufacturers identify unmet market needs, evaluate product opportunities, prioritize development pathways, and make strategic decisions amid growing industry pressure.
The discussion explores how pharmaceutical companies move from early-stage ideation to portfolio evaluation, development, commercialization, and lifecycle planning. As manufacturers face rising pricing pressure, market access barriers, regulatory expectations, competitive intensity, supply chain constraints, and evolving stakeholder demands, disciplined portfolio strategy has become more important than ever.
Listeners will gain perspective on how manufacturers are navigating uncertainty, adapting their growth strategies, and building more resilient portfolio models designed to bring meaningful therapies and solutions to market.
Special GuestJoe HendricksonHead of Strategy and Corporate Development Serovia
-
Today’s guest dropped an unbelievable amount of wisdom in the span of just one podcast episode. She and I both align on so many topics as you will discover in our conversation. We both believe that women have the power to intuit what is best for them and their bodies.Women, especially midlife women, have been taught for far too long that their suffering is "just a part of aging." The system has also taught us that when we have symptoms, we should reach for a drug to fix it (and often holistic medicine is thought of as an alternative herb or supplement).My guest asserts that when symptoms arrive for women in midlife and perimenopause, it is often a wake up call to how we are living our lives, particularly the accumulation of not so nourishing choices in the last couple of decades. Hormones shift, revealing what has already been happening. Women can then heed the call to pay attention to foundational living (how they are eating, sleeping, managing energy, stress, etc) and prevent further disease down the road.The common approach to manage symptoms with herbs and/or HRT are only addressing the tip of the iceberg and are not going to get at the root cause of symptoms. Perimenopause and menopause does not have to be a negative life sentence to the rest of your life, rather it can be seen as an initiation and invitation to finally start prioritizing yourself.Maria Gabriela is a certified Ayurveda Health Counselor, a doctor of pharmacy (Pharm.D.), a 200 hour certified yoga teacher, and founder of Intuitive Ayurveda. She helps people in perimenopause and menopause feel better in their bodies using Ayurveda, science-backed tools, and intuitive coaching — so they can celebrate this phase of life instead of dreading it.The eastern and western perspectives of medicine each have something to offer us, and Maria Gabriela understands this dance. Her goal is to educate on Ayurvedic tools that can (and should) be individualized to each complex person.She strives to help her clients tune into the messages their bodies are sending them. Ultimately, she believes every person is the expert on what is best for them, and can be empowered to hone in on which tools they need to support themselves in mind, body, and spirit.Connect with Maria Gabriela via:Email: [email protected]: Intuitive AyurvedaIG: @intuitive_ayurveda
-
This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind!
We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.
This is part six of our six part series!
We'd like to thank Finch Marketing for sponsoring this episode!
On this episode we interview:
Nicolle McClure - President, Finch Marketing
Seth Chaney - CEO, 609 Health
Natalie Ryan - Vice President of Specialty Pharmacy
Srulik Dvorsky - TailorMed
Michael Oleksiw and Abby Reynolds - Pleio
Fran Gregory - PharmD, Cardinal Health
-
This episode we look at some of the latest compounding news, and then we’ve got a deep dive into state-level legislation with the Leading Ladies of Pharmacy Compounding Advocacy.What bills are being introduced? What do they really mean when you read the detail? How will they affect state policies, and what could come next? And, of course, how are APC and compounding pharmacies fighting back against the bad bills that put patients at risk?If you’re a compounder, if you have patients who use compounded medications, or if you’re a patient yourself, you’ll want to hear this.Links from the podcast:The FDA statement on excluding GLP-1s from bulk compounding: https://fllw.me/491oGl3FDA Law Blog on the state of peptide compounding: https://fllw.me/4cpFF2C (part 1), https://fllw.me/4nxd13G (part 2)Is It Legit? to find a state-licensed compounding pharmacy: https://a4pc.org/isitlegitJoin APC! https://a4pc.org/join
-
Birth Rights, Medical Bills & Maternal Advocacy with Andi Orwoll, EsqIn this powerful episode of MaternalRx, Dr. Danielle Plummer sits down with Nevada attorney and founder of Your Legal Doula, Andi Orwoll, to discuss the often-overlooked legal and financial realities families face during pregnancy, birth, and postpartum recovery.From navigating IVF paperwork and unexpected C-sections to battling insurance denials and understanding birth rights, Andi shares how her own journey into motherhood inspired her to create a legal advocacy practice specifically for pregnant and postpartum families.This conversation explores the intersection of maternal health, patient advocacy, legal protections, informed consent, workplace rights, and the emotional toll of navigating the U.S. healthcare system during one of life’s most vulnerable seasons.In this episode, we discuss:- Why birth rights matter- The legal gaps in maternal healthcare- Insurance denials and surprise medical bills- IVF, fertility care, and the hidden administrative burden- Informed consent and patient advocacy during labor- The Pregnant Workers Fairness Act (PWFA)- The midwifery model of care vs. traditional obstetric care- Maternal mental load and postpartum vulnerability- Why tracking medical records, bills, and receipts matters- Navigating medical bills and insurance appealsKey Takeaways:“Policy never overrides your rights.”Andi explains how many patients are intimidated in medical settings and may not realize they have the legal right to informed consent, respectful care, and bodily autonomy during pregnancy and birth.Birth experiences matter.Even when outcomes are medically positive, the emotional and psychological experience of birth can have lasting effects. Advocacy, education, and support can profoundly shape those experiences.The paperwork burden is real.Pregnancy often comes with overwhelming administrative tasks: insurance appeals, billing disputes, maternity leave paperwork, provider reimbursements, and more — all during an emotionally and physically vulnerable time.Midwives, doulas, OBs, pharmacists, and lawyers all have a role.Maternal healthcare works best when it’s collaborative. This episode highlights the importance of interdisciplinary support systems for pregnant families.Track everything.One of the biggest practical pearls from this episode: keep copies of:- Medical bills- Insurance explanations of benefits (EOBs)- Receipts- Appointment dates- Correspondence with insurance companies- Workplace accommodation requestsDocumentation can make all the difference if problems arise later.About the Guest:Andi Orwoll is a Nevada-licensed attorney and founder of Your Legal Doula, a legal advocacy practice focused on supporting families navigating pregnancy, birth, postpartum recovery, workplace accommodations, and healthcare systems in the United States.Inspired by her own experience with IVF, an unexpected hospital birth, and overwhelming postpartum paperwork, Andi created Your Legal Doula to help families understand their rights and confidently advocate for themselves during pregnancy and birth.* Follow Andi:- https://yourlegaldoula.com/- Instagram @yourlegaldoulaAbout the Host:Danielle Plummer is a pharmacist, antepartum doula, and founder of Obstet-Rx. Through education, advocacy, and pharmacogenetics, she helps women navigate hyperemesis gravidarum and manage medications through complex pregnancy-related conditions.* Follow Danielle:- www.HGPharmacist.com- linkedin.com/in/daniellerplummerMemorable Quotes“We are not playing. We are here to have the birth experience that we want.”“Policy never overrides your rights.”“The most important work you are doing during your perinatal season should not be paperwork.”“The way we are treated during birth matters.”Resources Mentionedhttps://yourlegaldoula.com/https://hgpharmacist.com/Pregnant Workers Fairness Act (EEOC): www.eeoc.gov/Disclaimer:This podcast episode is intended for educational and informational purposes only and does not constitute legal or medical advice. The opinions expressed are those of the speakers and do not reflect the views of their employers or affiliated organizations.
-
In this episode of the PBM Reform Podcast, host Greg Reybold, Vice President and General Counsel at APCI, welcomes Josh Golden, Senior Vice President of Strategy at Judi Health and a nationally recognized voice in Pharmacy Benefit Manager reform.
With more than 20 years of healthcare consulting experience, Golden brings deep expertise in vendor procurement, contract negotiation, plan design, and benefit strategy for large employers, government entities, and unions. Together, Reybold and Golden examine the financial models behind today’s PBM industry and why true transparency remains so difficult for employers, plan sponsors, patients, and pharmacies.
The conversation explores how current PBM arrangements often benefit the PBMs more than the employers paying for coverage or the patients relying on their prescription benefits. Golden explains why auditing PBM contracts, rebate structures, spread pricing, administrative fees, pharmacy networks, and formulary decisions is essential to understanding the real economics of prescription drug benefits.
This episode also addresses a growing concern in healthcare: PBM steering behavior. Are patients being quietly pushed toward specific formularies, specific pharmacies, and restricted networks that operate like closed networks without being clearly disclosed? Reybold and Golden discuss how this behavior can limit patient choice, disadvantage independent pharmacies, and distort the stated goal of lowering drug costs.
The discussion also tackles the role of federal reform efforts, including whether the Appropriations Act represents meaningful PBM accountability or whether it risks becoming another layer in the broader shell game surrounding PBM reform.
Finally, the episode asks one of the most important questions in pharmacy policy today: should PBMs own pharmacies? If vertical integration is promoted as a way to lower drug costs, where is the proof — and who actually benefits?
Transparency, Auditing, and the PBM Shell Game | PBM Reform
-
This is a corporate-focused, conversational interview between Pharmacy Podcast Network Host, Todd Eury and Stephen Beckman, CEO of YARAL Pharma. The discussion explores YARAL Pharma’s unique approach to the U.S. generics market, its commitment to innovation and accessibility, and the company’s philosophy of “Doing Things Differently” by redefining what it means to be a generics partner.
Stephen Beckman also shares insights into YARAL’s growth and key milestones since launching its first product in 2023, including the expansion of its product portfolio, investment in business development, and focus on building a strong company culture.
Learn more at YARALPharma.com
-
On this episode of This Week in Pharmacy, we examine three major forces shaping healthcare today: the global impact of conflict on health security, the continued evolution of personalized specialty pharmacy care, and the over-the-counter products patients rely on most.
We open the show with Aman Gupta, Managing Partner, Asia-Pacific at SPAG FINN Partners, and contributor author at MedikaLife. Aman joins TWIRx to discuss his latest MedikaLife article, which argues that global conflict is quietly undermining health security by redirecting funding, attention, and infrastructure away from healthcare and toward defense priorities.
As military spending rises, health systems—especially in low- and middle-income countries—face growing pressure from shrinking access, rising costs, workforce shortages, disrupted supply chains, weakened disease surveillance, and reduced emergency preparedness. Conflicts in Ukraine, Gaza, and Sudan demonstrate how attacks on healthcare systems, displacement, malnutrition, and shortages of essential medicines can rapidly turn health access into a survival issue. Aman urges policymakers to treat health as strategic security infrastructure, not as a secondary social expense.
TWIRx also gives a special shout out to the Indian Pharmaceutical Association, recognizing its continued leadership and advocacy for the pharmacy profession.
Next, we welcome Dr. Chris Antypas, PharmD, with Perigon Pharmacy 360, for a discussion on how specialty pharmacy is becoming increasingly personalized. As complex therapies continue to advance, pharmacists are playing a critical role in ensuring medications and treatment plans are customized to optimize patient care. We explore how technology, workflow processes, clinical expertise, and pharmacists who deeply understand specific disease states are essential to successful specialty pharmacy outcomes.
To wrap up the episode, returning guest Shanley Chien Pierce, Senior Editor, Health at U.S. News & World Report, joins us to review the latest OTC medicine and health product evaluations. Top-rated products include Children’s Delsym for coughs, Unisom for sleep, and Pedialyte for electrolytes, along with skincare favorites such as La Roche-Posay for retinol and Aquaphor for lip balm.
For the full list covering more than 128 categories, visit the U.S. News Best OTC Medicine & Health Products rankings.
Sponsored by Perigon Pharmacy 360
Listen & SubscribeStay connected with This Week in Pharmacy and the Pharmacy Podcast Network for conversations with pharmacy leaders, healthcare innovators, policy experts, and industry voices shaping the future of care.
-
This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind!
We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.
This is part five of our six part series!
We'd like to thank PantherX Rare for sponsoring this episode!
On this episode we interview:
Katie DiLorenzo, PharmD SVP - PantherRx
Austin Russian - PantherRx
Autumn Santeler - Polar Tech Industries
Ben Heiser - Lumicera Health Services
Caroline Girardeau, PharmD, MBA ACHC
Chris Stewart - Petauri
Natalie Bedford - McKesson -
What's the difference between marketing and advertising and why does it matter for your pharmacy? In this episode of the Bottom Line Pharmacy Podcast, Austin Murray sits down with Bruce Kneeland, longtime independent pharmacy advocate and host of the Pharmacy Crossroads podcast, for a candid conversation about what it really takes to grow an independent pharmacy in today's competitive landscape.Bruce shares his fascinating journey from a chance job posting at BYU that landed him in Fargo, North Dakota, to senior roles at Health Mart, AmerisourceBergen, and eventually becoming a consultant and road-tripper who has visited pharmacies coast to coast.In this episode, Bruce and Austin cover:- Marketing vs. advertising and why confusing the two is costing pharmacies patients- The word-of-mouth myth and why relying on it alone is "killing you slowly"- Messaging that connects how to talk about complex services like compounding in language patients actually understand- The B2B opportunity and why your real customer for compounding and specialty services might be the prescriber, not the patientAnd more!
-
This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind!
We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.
This is part four of our six part series!
We'd like to thank JB Consulting for sponsoring this episode!
On this episode we interview:
Shaun Jensen - JB Consulting Group
Lindsay Greenleaf - ADVI
Magnar Kvilhaug - Odin Pharmacy Innovations LLC
Marina Allen - RxAccess Partners
Matt Hare - CoverMyMeds
Richard Brook - Better Health Worldwide
Valerie Mondelli and Colin Banas - DrFirst -
On this episode of This Week in Pharmacy, we examine two major forces reshaping the profession: the unfinished business of pharmacist provider status and the legal landscape around direct-to-consumer pharmaceutical distribution. In part one, Erik Abel, PharmD, MBA, discusses his May 2026 analysis, “So Pharmacists Want to Be a Provider: Where the Profession Lost Its Way and Perhaps a Path to Get Back.” Abel argues that pharmacy’s provider-status challenge is not a lack of clinical evidence, but a lack of operational infrastructure: credentialing, payer contracting, revenue cycle management, interoperability, and scalable business models. In part two, Darshan Kulkarni, PharmD, Esq., joins the show to discuss direct-to-consumer pharmaceutical distribution, legal risk, regulatory scrutiny, telehealth-linked prescribing, manufacturer strategy, and what pharmacists need to understand as drug distribution moves closer to the patient. This week in pharmacy news, Pittsburgh-area pharmacies continue to face uneven access to Adderall and other ADHD medications, years after the FDA first identified shortages in 2022. Patients are still calling multiple pharmacies, switching medications, rationing doses, or going without treatment as availability varies by dosage, formulation, manufacturer, and wholesaler. Pharmacists are also using medication therapy management to protect older adults from preventable medication-related harm. MTM reviews can identify risky prescriptions and OTC products, including diphenhydramine, duplicate therapies, drug interactions, and long-term proton pump inhibitor use that may need reassessment. In 340B news, CVS Health is facing federal lawsuits from major health systems alleging CVS Specialty and WellPartner improperly retained approximately $250 million in savings that should have gone back to covered entities. The litigation adds pressure to debates over PBM integration, contract pharmacy arrangements, and 340B transparency. On Capitol Hill, lawmakers are pressing the Department of Defense to commit to annual audits of the TRICARE pharmacy contract as concerns continue around PBM conflicts of interest, reimbursement practices, network adequacy, and access for independent and community pharmacies.
-
This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind!We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special. This is part three of our six part series!We'd like to thank Pergion Pharmacy 360 for sponsoring this episode!Chris Antypas PharmD - Perigon Pharmacy 360Chris Corsi - CassianRxChristen Roy - InovalonRobert Ojeda - K&B Pharmacy Associates
-
Today’s guest and I fundamentally agree on the basic premise of the body’s innate wisdom and capacity to heal, especially when we view it in a broader ecological context. According to him, infertility doesn't mean the body is broken; it's actually making intelligent, adaptive, and protective decisions made by the 4 foundational systems of the body that created life in the first place based on environmental conditions, resources, safety, and energy. Nick Dorsey, FDN-P, is a systems-based fertility and health educator, biochemist, and former chemistry educator who helps couples understand why fertility shuts down even when labs look normal and they're doing all the right things. With a Master's in biochemistry and over a decade teaching chemistry, physics, and environmental science, he translates complex biology into a clear understanding of how the body makes decisions. Nick’s research and experience supports that the body isn't broken, it's adapting intelligently to depletion, toxicity, and chronic stress, and symptoms like inflammation, fatigue, anxiety, gut dysfunction, and unexplained infertility are protective signals from a system in survival mode.Nick teaches health through the Four Pillars of biological readiness: the microbiome as the environmental interface, mitochondria as energy and resource allocators, minerals as the electrical and enzymatic stabilizers of physiology, and the nervous system as the regulator of safety and coherence. Rather than chasing symptoms, his work restores these systems so the body can repair, regulate, and reproduce when conditions are biologically appropriate. Functional labs reveal patterns of adaptation that explain why the body is saying not now, and what it needs next.Nick works with individuals and couples through high-touch, data-informed programs, with a long-term commitment to healthy pregnancies, births, and families across generations. He's a father of two with another on the way, both born at home, and long before biochemistry he spent most of his life teaching, coaching, and supporting children, including leading a youth ministry for kids with disabilities. Connect with Nick via:Email: [email protected] IG: @FunctionalChemistryYT: @FunctionalChemistry10
-
This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind!We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special. This is part two of our six part series!We'd like to thank Nested Knowledge for sponsoring this episode! On this episode we interview:Keith Kallmes - Nested KnowledgeHannah Baxter and Andrew Rouff, MMIT - The Dedham GroupHeather Bonome - URACJeremy Richardson - GifthealthJoe DePinto - McKessonJohny Kello - MatchRxShawn Griffin - URAC
-
This week, This Week in Pharmacy examines several stories shaping the business, clinical, and legal future of pharmacy practice.
In TWIRx News from Pharmacy Times from Megan Maroney, PharmD, BCPP, FAAPP, focused on antidepressant use, withdrawal concerns, deprescribing, and shared decision-making. The key takeaway: patients should never stop antidepressants abruptly. Pharmacists can play a vital role in reducing stigma, educating patients, and supporting safe conversations about tapering, side effects, and long-term treatment.
In health technology news, FDB research presented at the 2026 AMIA Amplify Informatics Conference found that patient-specific, risk-based medication guidance reduced pharmacy alert volume by 70% in a high-volume community pharmacy setting. The model consolidates alerts into one actionable message tied to the patient’s most relevant risk, helping reduce alert fatigue and improve workflow.
Finally, we review a federal court ruling in Eli Lilly’s lawsuit against Houston-based Empower Pharmacy over compounded tirzepatide versions of Mounjaro and Zepbound. The judge dismissed key federal trademark and Texas unfair competition claims, while allowing other state claims to continue.
Andy Crawford, with Keysource is back on TWIRx talking about the U.S. Supreme Court taking up Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc., a case that could significantly affect generic drug competition. At issue is whether Hikma’s marketing materials and public communications around its generic version of Amarin’s fish oil-based cardiovascular drug improperly promoted a still-patented use. Hikma and the broader generic industry argue the case is about protecting “skinny label” rules, which allow generics to carve out patented indications while still bringing lower-cost medications to market. For pharmacists, the decision could influence generic availability, substitution confidence, pricing pressure, and how manufacturers communicate with providers and pharmacies.
Thanks to our sponsors, CassianRx and IPC, for supporting independent pharmacy, innovation, and the future of patient-centered care. -
This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind!
We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special.
This is part one of our six part series!
We'd like to thank Clearway Health for sponsoring this episode!
On this episode we interview:
Allison Arant - Clearway Health
Jennifer Noonan - Accessia Health
Aleata Postell - CenterWell
Derek Dennis, PharmD - Clearway Health
Dr. Shafaat Pirani, PharmD, BCGP - Wellgistics Health
Meghna Misra - Claritas Rx
- Visa fler
